Hybrid imaging: beyond FDG PET/CT - ESR Connect

SPECIAL FOCUS SESSION

SF 9a - Hybrid imaging: beyond FDG PET/CT

  • 4 Lectures
  • 74 Minutes
  • 4 Speakers
No access granted. Register to watch.

Lectures

1
 SF 9a_3 - Hybrid PET and SPECT for cardiovascular imaging

SF 9a_3 - Hybrid PET and SPECT for cardiovascular imaging

20:51Albert Flotats, Barcelona / ES

Learning Objectives
1. To learn the clinical need for hybrid imaging in cardiovascular diseases.
2. To consider the role for both PET and SPECT imaging.
3. To learn the range of cardiovascular tracers that are used clinically and their role.

2
SF 9a_1 - Prostate specific membrane antigen (PSMA) hybrid imaging in guiding prostate cancer therapy

SF 9a_1 - Prostate specific membrane antigen (PSMA) hybrid imaging in guiding prostate cancer therapy

23:45Clemens C. Cyran, Munich / DE

Learning Objectives
1. To understand the biology of PSMA.
2. To consider different approaches to imaging PSMA and its use in therapy.
3. To learn about current clinical applications for guiding prostate therapy.

3
SF 9a_2 - Somatostatin receptor imaging and therapy

SF 9a_2 - Somatostatin receptor imaging and therapy

15:28Luigi Aloj, Cambridge / UK

4
SF 9a_4 - Imaging to guide immuno-oncology

SF 9a_4 - Imaging to guide immuno-oncology

13:59Umar Mahmood, Charlestown, MA / US

Learning Objectives
1. To understand the challenges of imaging response to immunomodulatory therapy.
2. To understand current standard of care imaging for immuno-oncology.
3. To understand some of the novel PET imaging approaches in clinical trials and development.

Description

SF 9a-1
Prostate specific membrane antigen (PSMA) hybrid imaging in guiding prostate cancer therapy
Clemens C. Cyran, Munich / DE
Learning Objectives
1. To understand the biology of PSMA.
2. To consider different approaches to imaging PSMA and its use in therapy.
3. To learn about current clinical applications for guiding prostate therapy.
SF 9a-2
Somatostatin receptor imaging and therapy
Luigi Aloj, Cambridge / UK
Learning Objectives
1. To understand the biology underlying somatostatin-based agents.
2. To consider different approaches to imaging and therapy through the use of the somatostatin receptor.
3. To learn about current clinical applications guiding prostate therapy.
SF 9a-3
Hybrid PET and SPECT for cardiovascular imaging
Albert Flotats, Barcelona / ES
Learning Objectives
1. To learn the clinical need for hybrid imaging in cardiovascular diseases.
2. To consider the role for both PET and SPECT imaging.
3. To learn the range of cardiovascular tracers that are used clinically and their role.
SF 9a-4
Imaging to guide immuno-oncology
Umar Mahmood, Charlestown, MA / US
Learning Objectives
1. To understand the challenges of imaging response to immunomodulatory therapy.
2. To understand current standard of care imaging for immuno-oncology.
3. To understand some of the novel PET imaging approaches in clinical trials and development.